Projects

Circulating microRNA a novel prognostic and diagnostic biomarker of prediabetes, Type 2 Diabetes and its complications among Indians.

Project Description

Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation. Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.

Project Duration

2019 - 2025

Project Lead

Dr Sucharitha S

Authors

Dr Sucharita S. Dr Jyothi P, Dr Ashwini P

Project Status

completed

Project Type

RGUHS